DNLI icon

Denali Therapeutics
DNLI

Overview Fund Activity

210 hedge funds and large institutions have $2.51B invested in Denali Therapeutics in 2024 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 76 increasing their positions, 69 reducing their positions, and 34 closing their positions.

Holders
210
Holders Change
+1
Holders Change %
+0.48%
% of All Funds
3.04%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.07%
New
36
Increased
76
Reduced
69
Closed
34
Calls
$2.5M
Puts
$2.46M
Net Calls
+$40K
Net Calls Change
-$300K

Top Buyers

1
Capital Research Global Investors
1
Capital Research Global Investors
California
$124M
2
CCM
2
Camber Capital Management
Massachusetts
$30.8M
3
Citadel Advisors
3
Citadel Advisors
Florida
$28M
4
BBA
4
Baker Bros. Advisors
New York
$76.6M
5
Wellington Management Group
5
Wellington Management Group
Massachusetts
$170M

Top Sellers

1
Federated Hermes
1
Federated Hermes
Pennsylvania
$0
2
Temasek Holdings
2
Temasek Holdings
Singapore
$117M
3
Morgan Stanley
3
Morgan Stanley
New York
$19M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$32.7M
5
FP
5
Flagship Pioneering
Massachusetts
$28M
Name Market Value Shares Shares
Change 		Shares
Change %
Baillie Gifford & Co
1
Baillie Gifford & Co
United Kingdom
$288M 14,041,228 -219,496 -2%
BlackRock
2
BlackRock
New York
$250M 12,199,856 +656,410 +6%
Vanguard Group
3
Vanguard Group
Pennsylvania
$225M 10,968,293 +133,810 +1%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$170M 8,269,949 +995,232 +14%
State Street
5
State Street
Massachusetts
$130M 6,323,872 +837,924 +15%
Capital Research Global Investors
6
Capital Research Global Investors
California
$124M 6,049,957 +3,140,429 +108%
Temasek Holdings
7
Temasek Holdings
Singapore
$117M 5,706,345 -1,189,647 -17%
CM
8
Crestline Management
Texas
$107M 5,210,732 -450,000 -8%
TPC
9
Takeda Pharmaceutical Company
Japan
$86.5M 4,214,559 – –
BBA
10
Baker Bros. Advisors
New York
$76.6M 3,731,695 +1,124,499 +43%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$56.6M 2,759,633 +100,337 +4%
Marshall Wace
12
Marshall Wace
United Kingdom
$44M 2,146,379 +478,982 +29%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$36.5M 1,777,907 -92,720 -5%
T. Rowe Price Associates
14
T. Rowe Price Associates
Maryland
$32.7M 1,594,333 -979,988 -38%
CS
15
Credit Suisse
Switzerland
$32.1M 1,566,246 -9,975 -0.6%
CCM
16
Camber Capital Management
Massachusetts
$30.8M 1,500,000 +1,500,000 New
Citadel Advisors
17
Citadel Advisors
Florida
$28M 1,365,028 +1,296,918 +1,904%
FP
18
Flagship Pioneering
Massachusetts
$28M 1,364,516 -955,452 -41%
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$27.4M 1,332,950 +213,322 +19%
CC
20
Casdin Capital
New York
$26.7M 1,300,000 – –
Norges Bank
21
Norges Bank
Norway
$25.4M 1,235,766 +83,120 +7%
Fidelity Investments
22
Fidelity Investments
Massachusetts
$25.3M 1,232,522 +590,869 +92%
GGHC
23
Gilder Gagnon Howe & Co
New York
$24.1M 1,172,785 -46,607 -4%
YCM
24
Yiheng Capital Management
California
$23.6M 1,150,684 – –
Principal Financial Group
25
Principal Financial Group
Iowa
$23M 1,122,536 +48,832 +5%
1
2 3 4 5